Jia-Horng Kao

115PUBLICATIONS
193CO-AUTHORS
Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (115)

|Sep 09, 2026
The Impact of HCC Surveillance on Tumor Features and Receipt of Curative Therapy: A Focus on Chronic Hepatitis B and MASLD.

|Aug 08, 2026
HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

|Jul 06, 2026
Artificial Intelligence-Assisted Screening for Patients With Diabetic Retinopathy and Age-Related Macular Degeneration in Family Medicine and Geriatric and Gerontology Care: Protocol for a Pragmatic Randomized Clinical Trial.

|Feb 27, 2026
Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification.

Tai-Chung Tseng, Shang-Chin Huang, Jia-Horng Kao

|Jan 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng

|Jan 06, 2026
IgG4-Associated Autoimmune Hepatitis: a Systematic Review.

Chun-Hsun Liao, Hsu-Hua Tseng, Ting-An Shen

Pageof 20

Frequent Collaborators

29 joint publications

Chen-Hua Liu

22 joint publications

Chun-Jen Liu

21 joint publications

Tung-Hung Su

16 joint publications

Cheng-Yuan Peng